BRISTOL-MYERS SQUIBB COMPANY

BMY · NEW YORK STOCK EXCHANGE INC.

Pharmaceutical Preparation Manufacturing · US

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

ESG Overview

Overall: BBB (High)

E: AS: BBG: BB

ESG grades from public dataset.

ESG data: Public Company ESG Ratings (CC BY-NC-SA 4.0)

Market Data

Price $60.84 +0.21 (+0.35%)

Market Cap$123.47B

P/E Ratio17.50

EPS$—

52W High$63.33

52W Low$42.52

Beta0.28

Data from Finnhub · Updated Mar 10, 2026